Cipher Genetics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$3.05M
- Investors
-
3
Cipher Genetics General Information
Description
Developer of a genetics-based health assessment platform designed for personalized health and wellness insights. The company's platform utilizes advanced AI technology and a single swab test to examine genes, offering data-driven assessments on weight balance, metabolism, cardiovascular function, hormone regulation, brain health and glucose control, enabling individuals and healthcare professionals to make informed decisions about lifestyle, nutrition and wellness strategies tailored to genetic predispositions.
Contact Information
Website
www.3x4genetics.comCorporate Office
- 3120 139th Avenue Southeast
- Suite 500
- Bellevue, WA 98005
- United States
Corporate Office
- 3120 139th Avenue Southeast
- Suite 500
- Bellevue, WA 98005
- United States
Cipher Genetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 27-Jan-2020 | $3.05M | Completed | Generating Revenue | ||
| 1. Angel (individual) | 01-Jan-2018 | Completed | Startup |
Cipher Genetics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
Cipher Genetics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cipher Genetics Patents
Cipher Genetics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024369591-A1 | Systems and methods for nutrigenomics and nutrigenetic analysis | Pending | 01-Nov-2023 | ||
| EP-4802534-A1 | Systems and methods for nutrigenomics and nutrigenetic analysis | Pending | 01-Nov-2023 | ||
| US-20250201381-A1 | Systems and methods for nutrigenomics and nutrigenetic analysis | Pending | 01-Nov-2023 | ||
| WO-2025096651-A1 | Systems and methods for nutrigenomics and nutrigenetic analysis | Inactive | 01-Nov-2023 | ||
| AU-2022313877-A1 | Systems and methods for genetics-based analytics of health, fitness and sports performance | Pending | 20-Jul-2021 | G16H50/30 |
Cipher Genetics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cipher Genetics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alethea Capital Management | Venture Capital | Minority | ||
| HAVAIC | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Cipher Genetics FAQs
-
When was Cipher Genetics founded?
Cipher Genetics was founded in 2018.
-
Where is Cipher Genetics headquartered?
Cipher Genetics is headquartered in Bellevue, WA.
-
What is the size of Cipher Genetics?
Cipher Genetics has 43 total employees.
-
What industry is Cipher Genetics in?
Cipher Genetics’s primary industry is Decision/Risk Analysis.
-
Is Cipher Genetics a private or public company?
Cipher Genetics is a Private company.
-
What is the current valuation of Cipher Genetics?
The current valuation of Cipher Genetics is .
-
What is Cipher Genetics’s current revenue?
The current revenue for Cipher Genetics is .
-
How much funding has Cipher Genetics raised over time?
Cipher Genetics has raised $3.42M.
-
Who are Cipher Genetics’s investors?
Alethea Capital Management, HAVAIC, and have invested in Cipher Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
